相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A New Perspective on Thyroid Hormones: Crosstalk with Reproductive Hormones in Females
Bingtao Ren et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor-Positive Recurrent or Metastatic Endometrial Cancer The VICTORIA Multicenter, Open-label, Phase 1/2 Randomized Clinical Trial
Pierre Heudel et al.
JAMA ONCOLOGY (2022)
Low T3 syndrome is associated with peripheral neuropathy in patients with type 2 diabetes mellitus
Weilei He et al.
MUSCLE & NERVE (2022)
Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Hypothyroidism affect progression and worse outcomes of breast cancer but not ovarian cancer
Mohamed M. Elgebaly et al.
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY (2021)
Thyroid Hormone Receptor β Inhibits Self-Renewal Capacity of Breast Cancer Stem Cells
Irene Lopez-Mateo et al.
THYROID (2020)
New therapeutic approaches for the fertility-sparing treatment of endometrial cancer
Akira Mitsuhashi et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2020)
Capivasertib, an AKT Kinase Inhibitor, as Monotherapy or in Combination with Fulvestrant in Patients with AKT1E17K-Mutant, ER-Positive Metastatic Breast Cancer
Lillian M. Smyth et al.
CLINICAL CANCER RESEARCH (2020)
Epidermal growth factor promotes stromal cells migration and invasion via up-regulation of hyaluronate synthase 2 and hyaluronan in endometriosis
Hong Zhan et al.
FERTILITY AND STERILITY (2020)
Thyroid Hormone Receptor Beta Induces a Tumor-Suppressive Program in Anaplastic Thyroid Cancer
Eric L. Bolf et al.
MOLECULAR CANCER RESEARCH (2020)
Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer
Sara E. Nunnery et al.
DRUGS (2020)
Rapid increase in endometrial cancer incidence and ethnic differences in New Zealand
Oliver W. Scott et al.
CANCER CAUSES & CONTROL (2019)
Comprehensive bioinformatics analysis of acquired progesterone resistance in endometrial cancer cell line
Wenzhi Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Metformin Enhances Nomegestrol Acetate Suppressing Growth of Endometrial Cancer Cells and May Correlate to Downregulating mTOR Activity In Vitro and In Vivo
Can Cao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Relationship between Hypothyroidism and Endometrial Cancer
Yiqin Wang et al.
AGING AND DISEASE (2019)
Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia
Rui Gao et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Nomegestrol Acetate Suppresses Human Endometrial Cancer RL95-2 Cells Proliferation In Vitro and In Vivo Possibly Related to Upregulating Expression of SUFU and Wnt7a
A-ying Ma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
PI3K/AKT/mTOR pathway promotes progestin resistance in endometrial cancer cells by inhibition of autophagy
Hua Liu et al.
ONCOTARGETS AND THERAPY (2017)
miR-205 inhibits cell growth by targeting AKT-mTOR signaling in progesterone-resistant endometrial cancer Ishikawa cells
Zhihong Zhuo et al.
ONCOTARGET (2017)
Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer
Mayu Yunokawa et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
Brian M. Slomovitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Subclinical Hypothyroidism Is Associated with Increased Risk for Cancer Mortality in Adult Taiwanese-A 10 Years Population-Based Cohort
Fen-Yu Tseng et al.
PLOS ONE (2015)
Medical Morbidities in Endometrial Cancer Patients
Siriwan Tangjitgamol et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Cooperation Between the Thyroid Hormone Receptor TRα1 and the WNT Pathway in the Induction of Intestinal Tumorigenesis
Elsa Kress et al.
GASTROENTEROLOGY (2010)
Role of Progesterone in Endometrial Cancer
J. Julie Kim et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2010)
Thyroid Hormone Receptor β1 Acts as a Potent Suppressor of Tumor Invasiveness and Metastasis
Olaia Martinez-Iglesias et al.
CANCER RESEARCH (2009)
Thyroid receptor: roles in cancer
Ana Aranda et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Sparing fertility in young patients with endometrial cancer
Luis Chiva et al.
GYNECOLOGIC ONCOLOGY (2008)
Biological roles of estrogen and progesterone in human endometrial carcinoma - New developments in potential endocrine therapy for endometrial cancer
Kiyoshi Ito et al.
ENDOCRINE JOURNAL (2007)
Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women
Kimio Ushijima et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Hypothyroidism: A possible risk factor for liver cancer in patients with no known underlying cause of liver disease
Arvind Reddy et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Thyroid hormone receptors/THR genes in human cancer
JM González-Sancho et al.
CANCER LETTERS (2003)
Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome
T Kaku et al.
CANCER LETTERS (2001)
分享论文
